BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
AcelRx Pharmaceuticals (ACRX) Receives CE Mark Approval For Zalviso 12/2/2014 10:31:16 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Four Upcoming Investor Events 11/20/2014 9:27:14 AM
AcelRx Pharmaceuticals (ACRX) Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/13/2014 9:05:13 AM
AcelRx Pharmaceuticals (ACRX) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:02 AM
AcelRx Pharmaceuticals (ACRX) Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System 11/10/2014 9:59:46 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Two Upcoming Investor Events 11/7/2014 8:29:36 AM
AcelRx Pharmaceuticals (ACRX) To Hold Third Quarter Financial Results Conference Call And Webcast On Monday, November 10, 2014 11/6/2014 8:37:34 AM
AcelRx Pharmaceuticals (ACRX) CEO Steps Down As Company Plots 2nd Try At Drug-Device Approval 11/5/2014 10:12:27 AM
AcelRx Pharmaceuticals (ACRX) Announces Sublingual Sufentanil Data Presentations At The American College of Surgeons Meeting 10/27/2014 8:10:01 AM
AcelRx Pharmaceuticals (ACRX)'s Zalviso Met Primary Endpoint In Phase 3 Study 10/22/2014 5:51:25 AM
12345678910...